Updated on 2023/11/30

写真a

 
SEINO Manabu
 

Degree

  • Doctor (Medicine), Yamagata University, 2016.09

 

Papers

  • Activation of estrogen receptor α by estradiol and cisplatin induces platinum-resistance in ovarian cancer cells., Cancer biology & therapy, 18(9) 730-739, 2017.09

    Matsumura S, Ohta T, Yamanouchi K, Liu Z, Sudo T, Kojimahara T, Seino M, Narumi M, Tsutsumi S, Takahashi T, Takahashi K, Kurachi H, Nagase S

    Multiple Authorship (Only Japanese)

  • Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel, Oncology Report, 2016.01

    Manabu Seino, Masashi Okada, Hirotsugu Sakaki, Hiroaki Takeda, Hikaru Watarai, Shuhei Suzuki, Sizuka Seino, Kenta Kuramoto, Tsuyoshi Ohta, Satoru Nagase, Hirohisa Kurachi, Chifumi Kitanaka

    Multiple Authorship (Only Japanese)

  • GSKJ4, A Selective Jumonji H3K27 Demethylase Inhibitor, Effectively Targets Ovarian Cancer Stem Cells., Anticancer research, 35(12) 6607-6614, 2015.12

    Sakaki H, Okada M, Kuramoto K, Takeda H, Watarai H, Suzuki S, Seino S, Seino M, Ohta T, Nagase S, Kurachi H, Kitanaka C

    Multiple Authorship (Only Japanese)

  • JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells., Oncotarget, 6(1) 458-470, 2015.01

    Suzuki S, Okada M, Shibuya K, Seino M, Sato A, Takeda H, Seino S, Yoshioka T, Kitanaka C

    Multiple Authorship (Only Japanese)

  • Differential contribution of ROS to resveratrol-induced cell death and loss of self-renewal capacity of ovarian cancer stem cells., Anticancer research, 35(1) 85-96, 2015.01

    Seino M, Okada M, Shibuya K, Seino S, Suzuki S, Takeda H, Ohta T, Kurachi H, Kitanaka C

    Multiple Authorship (Only Japanese)

  • Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells., Oncotarget, 6(2) 651-661, 2015.01

    Shibuya K, Okada M, Suzuki S, Seino M, Seino S, Takeda H, Kitanaka C

    Multiple Authorship (Only Japanese)

  • Requirement of JNK signaling for self-renewal and tumor-initiating capacity of ovarian cancer stem cells., Anticancer Research, 34(9) 4723-4731, 2014.09

    Manabu Seino, Masashi Okada, Keita Shibuya, Sizuka Seino, Shuhei Suzuki, Tsuyoshi Ohta, Hirohisa Kurachi, Chifumi Kitanaka

    Multiple Authorship (Only Japanese)

  • Targeting the K-Ras--JNK axis eliminates cancer stem-like cells and prevents pancreatic tumor formation., Oncotarget, 5(13) 5100-5112, 2014.07

    Okada M, Shibuya K, Sato A, Seino S, Suzuki S, Seino M, Kitanaka C

    Multiple Authorship (Only Japanese)

  • High levels of Wilms' tumor 1 (WT1) expression were associated with aggressive clinical features in ovarian cancer., Anticancer research, 34(5) 2331-2340, 2014.05

    Liu Z, Yamanouchi K, Ohtao T, Matsumura S, Seino M, Shridhar V, Takahashi T, Takahashi K, Kurachi H

    Multiple Authorship (Only Japanese)

  • JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expression., International journal of oncology, 44(2) 591-599, 2014.02

    Okada M, Sato A, Shibuya K, Watanabe E, Seino S, Suzuki S, Seino M, Narita Y, Shibui S, Kayama T, Kitanaka C

    Multiple Authorship (Only Japanese)

  • Specific role of JNK in the maintenance of the tumor-initiating capacity of A549 human non-small cell lung cancer cells., Oncology reports, 30(4) 1957-1964, 2013.10

    Okada M, Shibuya K, Sato A, Seino S, Watanabe E, Suzuki S, Seino M, Kitanaka C

    Multiple Authorship (Only Japanese)

display all >>

Grant-in-Aid for Scientific Research

  • Grant-in-Aid for Scientific Research(C),2021.04 - 2023.03

  • Grant-in-Aid for Scientific Research(C),2021.04 - 2023.03

  • Grant-in-Aid for Scientific Research(C),2018.04 - 2021.03

  • Grant-in-Aid for Scientific Research(C),2018.04 - 2020.03

  • Grant-in-Aid for Scientific Research(C),2018.04 - 2019.03

  • Grant-in-Aid for Young Scientists(B),2017.04 - 2019.03

display all >>